Cardio Diagnostics Holdings Inc - CDIO - Share chat

This is a cardiovascular medicine company harnessing artificial intelligence. They are developing technology that combines genetics and epigenetics to better understand and prevent heart diseases. Their main product, Epi+Gen CHD, is a test that assesses the risk of symptomatic coronary heart disease (CHD) over three years and helps predict events like heart attacks. Their other product, PrecisionCHD, is a blood test designed to detect coronary heart disease early.